Introduction
Extensive spread of pulmonary infections is a cause of global concern due to progressive increase in number of affected cases, particularly caused by the spread of acquired immune deficiency virus (AIDS) pandemic [1] . The intracelluar infectious 20 pulmonary pathogens are taken up by the alveolar macrophages, wherein resistance to biocidal and biophylactic mechanisms enable their rampant multiplication, consequently resulting in severe respiratory infections [1] [2] [3] [4] . Amongst the various infectious microorganisms, Mycobacterium tuberculosis remains one of the world's most notorious pathogens, this organism being singlehandedly responsible for millions of tuberculosis related mortalities, annually. Further, the emergence of multidrug-resistant M.
Tuberculosis underscores the need for new therapeutic approaches to combat this pathogen [5] .
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Amongst the numerous strategies being exploited worldwide to combat this pathogen, macrophage delivery is now considered as one of the most challenging and promising approaches [4, 6] . However, the success of this approach, in delivering chemical or nucleotide based drugs to the intracellular bacteria, is limited by inadequate specificity of the macrophages and their poor internalization of drug-carrier conjugates [6] [7] [8] [9] .
Though numerous delivery carriers, such as liposomes and lipidic nanoparticles have been previously explored for macrophage acetone. Further, the nanoparticles were optimized with respect to various parameters to provide the desired particle size, homogeneity and zeta potential for adequate complexation of nucleotides. The effect of various stabilizers like poloxamer 407, vitamin E-TPGS and PVA were evaluated, the results for which have been depicted in Fig. 1B and 1C . It was observed that ethyl acetate resulted in a lower particle size compared to acetone due to the partial solubility of ethyl acetate in water. It has been reported that solvents having partial solubility in water result in smaller nanoparticles than the solvents with high water solubility, 80 due to the ability to provide low interfacial tension at the aqueous-organic interphase. [30] . Additionally, low interfacial tension also facilitates a narrow distribution profile of the nanoparticles, as reflected by their low polydispersity index. As seen in Fig 1C, nanoparticle formulation containing DMC (ethyl acetate) in combination with PVA (100 µg/mL), exhibited an optimum particle size (170 nm ± 1.65 nm), polydispersity index (0.09 ± 0.003) and zeta potential (34.8 ± 0.97 mV) and hence was chosen for the further experiments involving complexation with nucleotide molecules. Various parameters like monodispersity, higher zeta 85 potential, stability and lung delivery were considered before choosing the optimum nanoparticle formulation.
Complexation of nanoparticles with nucleic acids
The optimized DMC nanoparticles demonstrated a positive zeta potential (34.8 ± 0.97 mV; Fig. 1 ), which allowed them to efficiently bind to the negatively charged nucleic acids. Preformed DMC nanoparticles were loaded with a combination of pUC 90 18-control plasmid DNA (pDNA) and siRNAs in the ratio of 3:1 w/w. The idea behind using preformed nanoparticles was to prevent the chemical, thermal or mechanical stresses associated with the process of nanoparticle formation from destroying the integrity and efficacy of the fragile siRNA molecules. The nucleotide combinations consisted of a cargo pDNA, non-functional in mammalian cells (pUC 18) and the respective siRNAs. The selection of type of pDNA assured that any biological action of the nanoplexes could be attributed only to the particular siRNA molecule. pDNA was used to enable efficient loading of MedChemComm 
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Three different types of siRNAs, namely Cy3 labeled control siRNA, anti-Luciferase siRNA (supporting information) and anti-Bfl1/A1 siRNA, were complexed with the DMC nanoparticles to demonstrate the cellular uptake and efficiency of the nanoplexes.
The complexation efficiency was studied over various weight ratios of nanoparticles to nucleic acids (pUC 18 and anti-Luciferase siRNA), ranging from 1:0.01 to 1:0.2 (w/w). The results have been presented in Fig. 2A . As seen from the figure, complete 115 binding of nucleotides was observed at weight ratio of 1:0.05, whereas excess nucleotides, at higher weight ratios, were observed as fluorescent bands during gel electrophoresis. The weight ratio of 1:0.05 was hence finalized for formulating the nanoparticles for further cellular evaluations. The particle size and polydispersity of nanoparticles increased with increase in nucleotide potential (23.11 ± 1.7mV). Higher weight ratios resulted in non-homegenous formulations, as indicated by increased PI, and substantial lowering of overall surface charge, and hence were not chosen for further studies.
Complexation with all the three siRNAs resulted in nanocomplexes with similar size, distribution and surface charge. The results have been depicted in Fig. 2B . However the overall surface charge of the nanoparticles was positive, in all cases, which was anticipated to improve their cellular uptake by interaction with negatively charged cell membranes. The surface of the nanoplexes exhibited a slight roughness, as compared to the unloaded nanoparticles ( Fig 3A) , which may be attributed to the adsorption pDNA-siRNA on the nanoparticle surface. 
Cytotoxicity Studies
The safety of the nanoparticles for various cellular evaluations was established by the MTT assay [20, 21] . The results of the MTT assay have been depicted in Fig.4 confirmed by this analysis. To confirm this internalization and to understand the mechanism of internalization of nanoparticles, confocal microscopy was performed (Fig. 6 ). The images indicate evident internalization of Cy-3 siRNA loaded nanoparticles (6A and 6B), denoted using arrows and circles. To further confirm these observations, z-stack of confocal images were analyzed 220 (6C and 6D). These images indicate that localization of nanoparticles between the cell membrane and nucleus. This enhanced cellular association and uptake may be attributed to electrostatic attractions overall cationic charge of the nanoparticles and the electronegative groups of the cell surfaces, in addition to hydrophobic association of the polymer with membrane structures as observed in earlier investigations [33] . To further understand the uptake mechanism, the cell uptake experiments were conducted in presence of inhibitors of various cell uptake pathways. Although various other types of Eudragit ® polymers have been 225 previously explored for [34, 35] nanoparticle formulations, this study is the first one to identify the precise endocytic pathway for DMC nanoparticles. The various inhibitors used during this experiment, along with the respective doses employed and the specific pathways inhibited by each, are shown in Table S1 in supporting information. The table also indicates the experimental protocol followed for each of these inhibitors with regards to their incubation time, with or without nanoparticles. In Presence of CHL, the nanoparticle uptake was normal and no specific inhibitory effect on nanoparticle was observed.
In Presence of NYS nanoparticle uptake was comparable as observed with chlorpromazine.
In presence of AML, the nanoparticle upake was severely restricted.
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MedChemComm The results support the observations shown by CLSM images and those of manual method for quantification of nanoparticles.
Also, our observations are in compliance with the earlier investigations with polymethacrylate (Eudragit) particles in various in vivo models, which speculate that in animal models these particles are taken up by macrophages via phagocytosis [40, 41] .
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In vitro Gene Silencing
Silencing of reporter Luciferase gene
In general, siRNA delivery is limited due to various physical and chemical barriers. Direct delivery of siRNA (without carrier) has only achieved reasonable efficiency and has shown limited efficiency upon local administration to specific tissues [42] . Thus development of an efficient carrier is a prerequisite for delivering siRNA in a biologically effective state. Various cationic 270 polymers like PEI, chitosan and their synthetic derivatives have been evaluated for this purpose. These polymers have exhibited inadequate success and despite their ability to improve the cell uptake and endosomal escape of the associated siRNA, they have resulted in low knockdown efficiency, mostly due to firm complexation and inadequate siRNA release [43, 44] .
The DMC nanoplexes (DMC nanoparticles loaded with anti-Luc siRNA) were evaluated for establishing the proof of biological efficacy of the formulated nanoparticles. These results have been discussed in depth in the supporting information of this 275 manuscript.
Bfl-1/A1 Gene silencing
Mycobacterium tuberculosis is an intracellular pathogen that primarily resides in host macrophages and utilizes the host cellular machinery for its survival. Though, extensive research is underway to understand the 'dependence factors' of mycobacteria inside macrophages, knowledge and proof is rather limited. However, recent research has provided several new targets to reduce 280 or diminish the bacterial growth inside the macrophages [45] . One of the important survival pathways for these bacteria is to prevent apoptosis of the cell. Studies have suggested that apoptosis of infected macrophages is prevented by mycobacteria, especially due to the virulence associated with these organisms. It has been demonstrated that proteins of the Bcl-2 family (Bfl1/A1), cytokines tumour necrosis factor-α (TNF-α) and interleukin-10 (IL-10) modulate apoptosis of infected macrophages.
Additionally, anti-apoptotic Bcl-2 proteins interact during mycobacterial infection and enhance their survival rate inside the 285 macrophages [46] [47] [48] . The role of Bfl1/A1, a member of Bcl-2 family of proteins, has been comprehensively explored in the pathogenesis of tuberculosis and it has been demonstrated that inhibition of Bfl1/A1 can limit the mycobacterial growth and hence spread of infection [18] . Thus in the present investigation DMC nanoparticles loaded with Bfl1/A1 siRNA, were evaluated in the macrophages (RAW 264.7) for their ability to enhance knockdown of anti-Bfl1/A1 siRNA and thus downregulate Bfl1/A1 expression. This was projected to have therapeutic significance for the treatment of tuberculosis.
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Expression of endogenous Bfl1/A1 was induced in RAW 264.7 cells using lipopolysachharide from E.Coli. Bfl-1/A1 is an NF-κB (Nuclear factor kappa B) dependent gene. Various studies have already demonstrated that LPS can stimulate NF-κB signaling and hence Bfl1/A1 expression in RAW 264.7 cells. [16, 17, 49] . The use of this model suggest an appropriate strategy to demonstrate anti-tubercular potential of the siRNA loaded polymeric nanoparticles without compromising on the safety issues associated in working with tuberculosis bacteria, in preliminary studies. 
Photon correlation spectroscopy and Zeta Potential
The hydrodynamic size and surface charge of DMC nanoparticles (Unloaded and Loaded) were determined by photon correlation 385 spectroscopy using a Zetasizer Nano ZS (Malvern Instruments, Malvern, UK). The experiments were conducted at 25 °C, after diluting the formulation with water, to guarantee that its light scattering intensity was within the instrument's sensitivity range.
Measurements were conducted in triplicates at a wavelength of 633nm and a backscattering angle of 173°. 
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ESEM
The morphological characteristics of the DMC nanoparticles (Unloaded and Loaded) were examined using a high resolution environmental scanning electron microscope (ESEM, FEI Quanta 400 FEG). For ESEM, one drop of dilute nanoparticles was placed on a small piece of silicon wafer and dried in the SEM chamber. Images were recorded at room temperature with an accelerating voltage of 20 kV and a pressure p = 100 Pa water. Wet-STEM investigations were done with a 2 µl drop of dilute 395 nanoparticles solution placed on a carbon coated copper TEM grid at an accelerating voltage of 30 kV and a pressure p = 800 Pa (T = 276 K).
Complexation of nanoparticles with nucleic acids
Gel electrophoresis was performed to evaluate the complexation of siRNA with DMC nanoparticles. The details of this method 400 have been provided in the supporting information.
Cell Viability
To evaluate cytotoxicity of nanoparticles, MTT assay was carried out using standard protocol [21] . We have used PEI as positive control in the experiment. The experimental details of MTT assay have been described in the supporting information.
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Intracellular Trafficking
Cell Association and Uptake: FACS
The association between DMC/siRNA (cy3 labeled) nanoparticles and RAW 264. 
